Researchers at the University of Seville have identified the possible origins of structural damage in the brains of patients with schizophrenia spectrum disorders (SSDs). These are regions that show ...
New brain imaging research shows that structural damage in schizophrenia spectrum disorders may begin in specific “epicenter” regions before spreading across connected brain networks.
Panelists discuss how schizophrenia’s immense personal and financial burden calls for early, integrated, and sustained care strategies. Panelists discuss how schizophrenia imposes a profound burden ...
Credit: Getty Images A literature review of nonpharmacologic treatments for patients with schizophrenia and comparison recommendations in the 2020 American Psychiatric Association Practice (APA) ...
MIAMI LAKES, Fla.--(BUSINESS WIRE)--Segal Trials, a privately held clinical research network specializing in acute schizophrenia and other psychiatric disorders, has released enrollment performance ...
BOSTON--(BUSINESS WIRE)--Adams Clinical, LLC (“Adams”, or the “Company”), a leading Neuroscience-focused clinical trial site network announced today that it has agreed on terms of the intent to ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For patients ...
A research team led by Professor Takahiro Nemoto at Toho University, in collaboration with Associate Professor Naoki Hashimoto and Assistant Professor Ryo Okubo at Hokkaido University, and Dr. Satoru ...
Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic lateral sclerosis (ALS), has now set its sights on using the pill to provide a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback